- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 91.03M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.49B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.49B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $198.32M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $220.96M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.85B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.84B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $479.24M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $541.72M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.64B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.64B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $428.45M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $419.06M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 93.79M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $8.77M |
| Capex | Q1 2025 · Mar 31, 2024 | $43.67M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $66.69M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$286.07M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$313.7M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.15 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.16 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $45.77M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $32.93M |
| Net Income | Q1 2025 · Mar 31, 2024 | $14.14M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $11.54M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $109.15M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $75.58M |
| Revenue | Q1 2025 · Mar 31, 2024 | $184.73M |